California’s highest court rules for Gilead in ‘duty to innovate’ case

Gilead wins California Supreme Court case around HIV drugs

California Supreme Court sides with Gilead in ‘duty’ to innovate case

Advocates argued Gilead was negligent for slow-walking development of an HIV medicine that was safer than another drug it was already selling.

Gilead wins California high court ruling involving 'duty to innovate' theory

California Supreme Court backs Gilead in HIV drug lawsuit over safer drug development.

California’s highest court rules for Gilead in ‘duty to innovate’ case

Aug 3 (Reuters) - California's ​highest ‌court on Monday ‌ruled ​in ⁠favor of ⁠Gilead Sciences, in ​a ⁠case ⁠addressing whether ​manufacturers ​of drugs that ‌are considered ⁠safe must try ⁠developing ‌drugs ⁠that ​could ‌be safer. (Reporting ​by ⁠Jon...

California Supreme Court Decision Protects Future Medical Innovation

PRI Celebrates Victory After Filing Amicus Brief in Landmark Gilead Case The Pacific Research Institute – the non-partisan, California-based, free-market think tank – today hailed a landmark California Supreme Court decision protecting future medical innovation. The ruling in the Gilead Tenofir Cases overturns a lower court decision that threatened to expose pharmaceutical innovators to sweeping new liability for decisions about the timing of t…